Akihiro Nishimura

Kobe, 6500017, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Distinct Clinical Significance of Minimal Residual Disease Detected by 7NB-mRNAs Expression in Bone Marrow at Different Time Points of High-Risk Neuroblastoma Patients.

Distinct Clinical Significance of Minimal Residual Disease Detected by 7NB-mRNAs Expression in Bone Marrow at Different Time Points of High-Risk Neuroblastoma Patients.

Journal: Biology

Published: January 12, 2026

Pediatric coronavirus disease 2019 clinical characteristics in a primary emergency medical center: Comparative analysis of BA.1/BA.2, BA.5/BQ.1, and XBB periods.

Pediatric coronavirus disease 2019 clinical characteristics in a primary emergency medical center: Comparative analysis of BA.1/BA.2, BA.5/BQ.1, and XBB periods.

Journal: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy

Published: December 29, 2025

Increase in the age of onset of pediatric acute otitis media after the Covid-19 pandemic: A study at a primary emergency medical center.

Increase in the age of onset of pediatric acute otitis media after the Covid-19 pandemic: A study at a primary emergency medical center.

Journal: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy

Published: July 31, 2025

Evaluation of Minimal Residual Disease in Patients with Neuroblastoma.

Evaluation of Minimal Residual Disease in Patients with Neuroblastoma.

Journal: Molecular diagnosis & therapy

Published: May 04, 2025

KMT2A-CBL fusion gene in the first reported case of T-cell acute lymphoblastic leukemia associated with Wiedemann-Steiner syndrome.

KMT2A-CBL fusion gene in the first reported case of T-cell acute lymphoblastic leukemia associated with Wiedemann-Steiner syndrome.

Journal: International journal of hematology

Published: September 25, 2024

Distinct Expression Profiles of Neuroblastoma-Associated mRNAs in Peripheral Blood and Bone Marrow of Non-High-Risk and High-Risk Neuroblastoma Patients.

Distinct Expression Profiles of Neuroblastoma-Associated mRNAs in Peripheral Blood and Bone Marrow of Non-High-Risk and High-Risk Neuroblastoma Patients.

Journal: Biology

Published: April 13, 2024

Higher levels of minimal residual disease in peripheral blood than bone marrow before 1st and 2nd relapse/regrowth in a patient with high‑risk neuroblastoma: A case report.

Higher levels of minimal residual disease in peripheral blood than bone marrow before 1st and 2nd relapse/regrowth in a patient with high‑risk neuroblastoma: A case report.

Journal: Oncology letters

Published: January 15, 2023

Minimal residual disease detected by droplet digital PCR in peripheral blood stem cell grafts has a prognostic impact on high-risk neuroblastoma patients.

Minimal residual disease detected by droplet digital PCR in peripheral blood stem cell grafts has a prognostic impact on high-risk neuroblastoma patients.

Journal: Heliyon

Published: September 21, 2022

Epidural Spinal Cord Compression as the Presenting Manifestation of Acute Myeloid Leukemia: A Case Report and Literature Review.

Epidural Spinal Cord Compression as the Presenting Manifestation of Acute Myeloid Leukemia: A Case Report and Literature Review.

Journal: Internal medicine (Tokyo, Japan)

Published: July 06, 2022

The comparison of acute toxicities associated with craniospinal irradiation between photon beam therapy and proton beam therapy in children with brain tumors.

The comparison of acute toxicities associated with craniospinal irradiation between photon beam therapy and proton beam therapy in children with brain tumors.

Journal: Cancer medicine

Published: October 14, 2021

Showing 1-10 of 10

Last Updated: 09/26/2026